Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
19,169
Total Claims
$466K
Drug Cost
500
Beneficiaries
$932
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-98%
Opioid rate vs peers
0.1% vs 2.6% avg
-13%
Cost per patient vs peers
$932 vs $1,068 avg
-50%
Brand preference vs peers
4.5% vs 9.0% avg
Opioid Prescribing
0.1%
Opioid Rate
11
Opioid Claims
$34
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 864 claims · $249K
Generic: 18,177 claims · $213K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phosphate | 36 | $21K |
| Rivaroxaban | 33 | $18K |
| Insulin Glargine,hum.Rec.Anlog | 51 | $18K |
| Sacubitril/Valsartan | 26 | $17K |
| Apixaban | 26 | $15K |
| Dapagliflozin Propanediol | 24 | $14K |
| Semaglutide | 12 | $12K |
| Diclofenac Sodium | 196 | $11K |
| Levothyroxine Sodium | 657 | $9,850 |
| Budesonide/Formoterol Fumarate | 33 | $8,996 |
| Fenofibrate | 64 | $8,654 |
| Rosuvastatin Calcium | 1,175 | $8,409 |
| Albuterol Sulfate | 201 | $7,393 |
| Insulin Aspart Prot/Insuln Asp | 13 | $6,637 |
| Gabapentin | 847 | $6,539 |
Prescribing Profile
Patient Profile
74
Avg Age
50%
Female
2.09
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data